Rankings
▼
Calendar
VCEL Q2 2024 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$53M
+14.7% YoY
Gross Profit
$37M
69.5% margin
Operating Income
-$6M
-11.5% margin
Net Income
-$5M
-8.9% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+2.7%
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
$2M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$377M
Total Liabilities
$134M
Stockholders' Equity
$243M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$53M
$46M
+14.7%
Gross Profit
$37M
$30M
+22.2%
Operating Income
-$6M
-$6M
-1.2%
Net Income
-$5M
-$5M
+6.7%
Revenue Segments
MACI Implants And Kits
$44M
100%
← FY 2024
All Quarters
Q3 2024 →